封面
市场调查报告书
商品编码
1185363

生物技术市场研究报告:按技术(基于细胞的测定,色谱法,DNA 测序),应用,区域-COVID-19,俄乌衝突和高通货膨胀的累积影响 - 2023-2030 年全球预测

Biotechnology Market Research Report by Technology (Cell-Based Assays, Chromatography, and DNA Sequencing), Application, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, High Inflation - Global Forecast 2023-2030

出版日期: | 出版商: 360iResearch | 英文 249 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2022年全球生物技术市场规模预计为12315亿美元,预计2023年将达到11953亿美元,2030年将达到35833.6亿美元,预计复合年增长率为16.96%。

俄乌衝突的累积影响。

鑑于俄乌衝突造成的政治和经济不确定性,我们不断监测和更新我们的报告。预计将在全球范围内产生负面影响,尤其是在东欧、欧盟、东/中亚和美国。衝突对人们的生活和生计产生了深远影响,并普遍扰乱了贸易动态。东欧正在进行的战争和不确定性的潜在影响预计将对乌克兰产生负面影响,并对俄罗斯产生严重的长期后果。鑑于有关供需平衡、价格压力、对进出口和贸易的影响、衝突以及全球对冲突的反应的最新信息,本报告为全球生物技术市场提供了近期建议。

高通膨的累积效应。

世界新兴经济体的高通胀导致过去两年整体价格上涨。整体购买力的累积侵蚀预计将对新兴经济体产生重大影响,并被认为在许多方面都很有用。本报告强调了高通胀对全球经济长期表现的影响,并详细介绍了财政政策如何衡量和减轻对供需、现金流和汇率的短期影响。考虑到成本推动型通胀和需求拉动型通胀的相关影响,全球生物技术市场报告提供了高通胀预期。

市场统计

该报告提供了七种主要货币的市场规模和预测:美元、欧元、日元、英镑、澳元、加元和瑞士法郎,使组织领导者能够做出更好的决策。我们帮助您做到这一点。本报告将2018年和2021年作为过去年份,2022年作为基准年,2023年作为可能年,2024-2030年作为预测期。

市场细分和覆盖

全球生物技术市场报告确定了客户的关键属性,以定义潜在市场并确定各行业的不同需求。了解潜在客户群的经济体和地理位置有助于获得业务洞察力,从而做出更好的战略决策。在这份报告中,我们通过涵盖各个行业的市场研究来揭示每个行业参与者战略背后隐藏的真相,并帮助企业决定将目标锁定在谁身上。该报告提供了具有全面行业范围的组合子市场的综合视图,提供了考虑规范和法规、文化等因素的正确方法,以製定正确的市场规划覆盖策略。本研究报告对全球生物技术市场进行了分类,并预测了以下每个子市场的收入和趋势:

以技术为基础,通过基于细胞的分析、层析、DNA 测序、发酵、纳米生物技术、PCR 技术、组织工程和再生来探索市场。

通过应用,我们正在研究生物信息学、食品/农业、健康、工业加工和自然资源/环境。

按地区划分,研究在美洲、亚太地区、欧洲和中东/非洲进行。美洲还探索阿根廷、巴西、加拿大、墨西哥和美国的地区。美国在加利福尼亚州、佛罗里达州、伊利诺伊州、纽约州、俄亥俄州、宾夕法尼亚州和德克萨斯州进行了进一步探索。亚太地区在澳大利亚、中国、印度、印度尼西亚、日本、马来西亚、菲律宾、新加坡、韩国、台湾、泰国和越南得到进一步探索。欧洲/中东/非洲包括丹麦、埃及、芬兰、法国、德国、以色列、意大利、荷兰、尼日利亚、挪威、波兰、卡塔尔、俄罗斯、沙特阿拉伯、南非、西班牙、瑞典、瑞士、土耳其、阿拉伯联合酋长国,进一步研究英国。

FPNV定位矩阵。

FPNV 定位矩阵:全球生物技术市场供应商的评级和分类。四个像限(F:Forefront,P:Pathfinder,N:Niche,V:Vital)。全球生物技术市场的 FPNV 定位表示/可视化进一步帮助公司做出更好的决策和了解竞争格局。

市场份额分析:

市场份额分析分析了供应商对整个市场的贡献,并提供了与同一领域的其他供应商相比,整个市场的创收情况。这可以深入了解供应商在创收和客户群方面相对于其他供应商的表现。全球生物技术市场份额分析揭示了供应商在基准年的规模和竞争力。结果揭示了市场在积累、分散、支配和合併特征方面的特征。

该报告提供了以下几点的见解:

1- 市场渗透:提供主要参与者所服务市场的全面信息。

2- 市场开发:提供有关利润丰厚的新兴市场的详细信息,并分析成熟市场的渗透率。

3- 市场多元化:提供有关新产品发布、未开发领域、近期发展和投资的详细信息

4- 市场趋势。全面了解 COVID-19、俄乌衝突和高通胀的累积影响。

5- 竞争评估和信息:对主要参与者的市场份额、战略、产品、认证、监管批准、专利状态和製造能力进行深入评估。

6- 产品开发和创新:提供对未来技术、研发活动和突破性产品开发的智力洞察。

本报告回答了以下问题:

1- 全球生物技术市场的市场规模和预测是什么?

2- COVID-19 在预测期内塑造全球生物技术市场的抑制因素和影响是什么?

3-在预测期内应投资全球生物技术市场的哪些产品/细分/应用/领域?

4- 全球生物技术市场的竞争战略窗口是什么?

5- 全球生物技术市场的技术趋势和监管框架是什么?

6- 全球生物技术市场主要供应商的市场份额是多少?

7- 哪些模式或战略举措被认为适合进入全球生物技术市场?

目录

第一章 前言

  • 调查目的
  • 市场细分和覆盖
  • 调查目标年份
  • 货币和价格
  • 限制
  • 先决条件
  • 利益相关者

第二章研究方法论

  • 定义:研究目的
  • 决定:调查设计
  • 准备:创建问卷
  • 收集:数据源
  • 分析:数据解释
  • 公式:数据验证
  • 发表:研究报告创作
  • 重复:更新报告

第三章执行摘要

第四章市场概况

第 5 章市场洞察

  • 市场动态
    • 促进者
      • 对膳食补充剂和园艺产品的兴趣日益增长
      • 持续健康状况的发生率增加
      • 对个性化医疗和疾病早期发现的需求激增
    • 抑製剂
      • 与基因数据相关的风险
    • 商机
      • 创新技术的出现
      • 对农产品的需求不断增长
    • 任务
      • 生物技术对环境的负面影响
  • COVID-19 的累积影响
  • 俄乌衝突的累积影响
  • 高通胀的累积效应
  • 波特五力分析
    • 新进入者的威胁
    • 替代品的威胁
    • 替代品的威胁
    • 替代品的威胁
    • 产业竞争力
  • 价值炼和关键路径分析
  • 监管框架
  • 客户定制

6. 生物技术市场,按技术分类

  • 基于细胞的检测
  • 色谱法
  • DNA测序
  • 发酵
  • 纳米生物技术
  • PCR技术
  • 组织工程与再生

7. 生物技术市场,按应用

  • 生物信息学
  • 食品/农业
  • 健康领域
  • 工业加工
  • 资源/环境

8.美洲生物技术市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太生物技术市场

  • 澳大利亚
  • 中国
  • 印度
  • 印度尼西亚
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第 10 章欧洲/中东/非洲生物技术市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 意大利
  • 荷兰
  • 尼日利亚
  • 挪威
  • 波兰
  • 卡塔尔
  • 俄罗斯
  • 沙特阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯联合酋长国
  • 英国

第十一章竞争格局

  • FPNV定位矩阵
    • 象限
    • 经营策略
    • 产品满意度
  • 主要参与者的市场排名分析
  • 市场份额分析(主要参与者)
  • 主要参与者的产品组合分析
  • 竞争情景
    • 合併/收购
    • 协议、合作和伙伴关係
    • 新品发布及功能增强
    • 投资、筹款
    • 奖项/表彰/扩展

第 12 章企业可用性简介

  • Abbott Laboratories Ltd.
  • Agilent Technologies, Inc.
  • Amgen Inc.
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • General Electric Company
  • Gilead Sciences, Inc.
  • Lonza Group
  • Novartis AG
  • Novo Nordisk A/S
  • PerkinElmer, Inc.
  • QIAGEN
  • Samudra Biopharma Pvt. Ltd
  • Thermo Fisher Scientific Inc

第十三章附录

  • 讨论指南
  • 关于许可证和价格
Product Code: MRR-434CCDA04CA7

The Global Biotechnology Market size was estimated at USD 1,023.15 billion in 2022 and expected to reach USD 1,195.30 billion in 2023, projecting growth at a CAGR of 16.96% to reach USD 3,583.36 billion by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global Biotechnology Market.

Cumulative Impact of Russia-Ukraine Conflict:

We continuously monitor and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people's lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global Biotechnology Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global Biotechnology Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global Biotechnology Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan. This research report categorizes the Global Biotechnology Market in order to forecast the revenues and analyze the trends in each of the following sub-markets.

Based on Technology, the market is studied across Cell-Based Assays, Chromatography, DNA Sequencing, Fermentation, Nanobiotechnology, PCR Technology, and Tissue Engineering & Regeneration.

Based on Application, the market is studied across Bioinformatics, Food & Agriculture, Health, Industrial Processing, and Natural Resources & Environment.

Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Biotechnology Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global Biotechnology Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global Biotechnology Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global Biotechnology Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor's strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Biotechnology Market, including Abbott Laboratories Ltd., Agilent Technologies, Inc., Amgen Inc., Bio-Rad Laboratories, Inc., bioMerieux SA, Danaher Corporation, F. Hoffmann-La Roche AG, General Electric Company, Gilead Sciences, Inc., Lonza Group, Novartis AG, Novo Nordisk A/S, PerkinElmer, Inc., QIAGEN, Samudra Biopharma Pvt. Ltd, and Thermo Fisher Scientific Inc.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Biotechnology Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biotechnology Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biotechnology Market?

4. What is the competitive strategic window for opportunities in the Global Biotechnology Market?

5. What are the technology trends and regulatory frameworks in the Global Biotechnology Market?

6. What is the market share of the leading vendors in the Global Biotechnology Market?

7. What modes and strategic moves are considered suitable for entering the Global Biotechnology Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising interest for sustenance and horticultural items
      • 5.1.1.2. Growing incidence of persistent health conditions
      • 5.1.1.3. Surging demand for personalized medicines coupled with the early detection of diseases
    • 5.1.2. Restraints
      • 5.1.2.1. Risk associated to genetic data
    • 5.1.3. Opportunities
      • 5.1.3.1. Emergence of innovative technologies
      • 5.1.3.2. Escalating demand for agriculture-based products
    • 5.1.4. Challenges
      • 5.1.4.1. Adverse environmental impact due to biotechnology
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Cumulative Impact of Russia-Ukraine Conflict
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Threat of Substitutes
    • 5.5.4. Threat of Substitutes
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework
  • 5.8. Client Customization

6. Biotechnology Market, by Technology

  • 6.1. Introduction
  • 6.2. Cell-Based Assays
  • 6.3. Chromatography
  • 6.4. DNA Sequencing
  • 6.5. Fermentation
  • 6.6. Nanobiotechnology
  • 6.7. PCR Technology
  • 6.8. Tissue Engineering & Regeneration

7. Biotechnology Market, by Application

  • 7.1. Introduction
  • 7.2. Bioinformatics
  • 7.3. Food & Agriculture
  • 7.4. Health
  • 7.5. Industrial Processing
  • 7.6. Natural Resources & Environment

8. Americas Biotechnology Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Biotechnology Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Biotechnology Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis, By Key Player
  • 11.3. Market Share Analysis, By Key Player
  • 11.4. Product Portfolio Analysis, By Key Player
  • 11.5. Competitive Scenario
    • 11.5.1. Merger & Acquisition
    • 11.5.2. Agreement, Collaboration, & Partnership
    • 11.5.3. New Product Launch & Enhancement
    • 11.5.4. Investment & Funding
    • 11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Abbott Laboratories Ltd.
  • 12.2. Agilent Technologies, Inc.
  • 12.3. Amgen Inc.
  • 12.4. Bio-Rad Laboratories, Inc.
  • 12.5. bioMerieux SA
  • 12.6. Danaher Corporation
  • 12.7. F. Hoffmann-La Roche AG
  • 12.8. General Electric Company
  • 12.9. Gilead Sciences, Inc.
  • 12.10. Lonza Group
  • 12.11. Novartis AG
  • 12.12. Novo Nordisk A/S
  • 12.13. PerkinElmer, Inc.
  • 12.14. QIAGEN
  • 12.15. Samudra Biopharma Pvt. Ltd
  • 12.16. Thermo Fisher Scientific Inc

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOTECHNOLOGY MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL BIOTECHNOLOGY MARKET SIZE, 2022 VS 2030
  • FIGURE 3. GLOBAL BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 4. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD BILLION)
  • FIGURE 6. GLOBAL BIOTECHNOLOGY MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2030
  • FIGURE 7. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 8. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
  • FIGURE 9. GLOBAL BIOTECHNOLOGY MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
  • FIGURE 10. GLOBAL BIOTECHNOLOGY MARKET DYNAMICS
  • FIGURE 11. GLOBAL BIOTECHNOLOGY MARKET PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 12. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
  • FIGURE 13. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD BILLION)
  • FIGURE 14. GLOBAL BIOTECHNOLOGY MARKET COMPETITIVE STRATEGIC WINDOW, BY TECHNOLOGY, 2030
  • FIGURE 15. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD BILLION)
  • FIGURE 16. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD BILLION)
  • FIGURE 17. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY DNA SEQUENCING, 2018-2030 (USD BILLION)
  • FIGURE 18. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY FERMENTATION, 2018-2030 (USD BILLION)
  • FIGURE 19. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY NANOBIOTECHNOLOGY, 2018-2030 (USD BILLION)
  • FIGURE 20. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD BILLION)
  • FIGURE 21. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY TISSUE ENGINEERING & REGENERATION, 2018-2030 (USD BILLION)
  • FIGURE 22. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 23. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD BILLION)
  • FIGURE 24. GLOBAL BIOTECHNOLOGY MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2030
  • FIGURE 25. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY BIOINFORMATICS, 2018-2030 (USD BILLION)
  • FIGURE 26. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY FOOD & AGRICULTURE, 2018-2030 (USD BILLION)
  • FIGURE 27. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY HEALTH, 2018-2030 (USD BILLION)
  • FIGURE 28. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY INDUSTRIAL PROCESSING, 2018-2030 (USD BILLION)
  • FIGURE 29. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY NATURAL RESOURCES & ENVIRONMENT, 2018-2030 (USD BILLION)
  • FIGURE 30. AMERICAS BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 31. AMERICAS BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 32. AMERICAS BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
  • FIGURE 33. AMERICAS BIOTECHNOLOGY MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
  • FIGURE 34. ARGENTINA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 35. BRAZIL BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 36. CANADA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 37. MEXICO BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 38. UNITED STATES BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 39. UNITED STATES BIOTECHNOLOGY MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 40. UNITED STATES BIOTECHNOLOGY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD BILLION)
  • FIGURE 41. UNITED STATES BIOTECHNOLOGY MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
  • FIGURE 42. ASIA-PACIFIC BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 43. ASIA-PACIFIC BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 44. ASIA-PACIFIC BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
  • FIGURE 45. ASIA-PACIFIC BIOTECHNOLOGY MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
  • FIGURE 46. AUSTRALIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 47. CHINA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 48. INDIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 49. INDONESIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 50. JAPAN BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 51. MALAYSIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 52. PHILIPPINES BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 53. SINGAPORE BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 54. SOUTH KOREA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 55. TAIWAN BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 56. THAILAND BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 57. VIETNAM BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 58. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 59. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 60. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
  • FIGURE 61. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
  • FIGURE 62. DENMARK BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 63. EGYPT BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 64. FINLAND BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 65. FRANCE BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 66. GERMANY BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 67. ISRAEL BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 68. ITALY BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 69. NETHERLANDS BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 70. NIGERIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 71. NORWAY BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 72. POLAND BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 73. QATAR BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 74. RUSSIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 75. SAUDI ARABIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 76. SOUTH AFRICA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 77. SPAIN BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 78. SWEDEN BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 79. SWITZERLAND BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 80. TURKEY BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 81. UNITED ARAB EMIRATES BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 82. UNITED KINGDOM BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • FIGURE 83. GLOBAL BIOTECHNOLOGY MARKET: FPNV POSITIONING MATRIX, 2022
  • FIGURE 84. GLOBAL BIOTECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2022
  • FIGURE 85. GLOBAL BIOTECHNOLOGY MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022

LIST OF TABLES

  • TABLE 1. GLOBAL BIOTECHNOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. GLOBAL BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 4. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 5. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
  • TABLE 6. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 7. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD BILLION)
  • TABLE 8. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY CELL-BASED ASSAYS, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 9. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY CELL-BASED ASSAYS, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 10. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD BILLION)
  • TABLE 11. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 12. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 13. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY DNA SEQUENCING, 2018-2030 (USD BILLION)
  • TABLE 14. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 15. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 16. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY FERMENTATION, 2018-2030 (USD BILLION)
  • TABLE 17. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY FERMENTATION, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 18. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY FERMENTATION, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 19. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY NANOBIOTECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 20. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY NANOBIOTECHNOLOGY, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 21. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY NANOBIOTECHNOLOGY, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 22. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 23. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY PCR TECHNOLOGY, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 24. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY PCR TECHNOLOGY, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 25. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY TISSUE ENGINEERING & REGENERATION, 2018-2030 (USD BILLION)
  • TABLE 26. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY TISSUE ENGINEERING & REGENERATION, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 27. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY TISSUE ENGINEERING & REGENERATION, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 28. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 29. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY BIOINFORMATICS, 2018-2030 (USD BILLION)
  • TABLE 30. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 31. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 32. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY FOOD & AGRICULTURE, 2018-2030 (USD BILLION)
  • TABLE 33. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY FOOD & AGRICULTURE, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 34. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY FOOD & AGRICULTURE, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 35. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY HEALTH, 2018-2030 (USD BILLION)
  • TABLE 36. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY HEALTH, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 37. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY HEALTH, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 38. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY INDUSTRIAL PROCESSING, 2018-2030 (USD BILLION)
  • TABLE 39. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY INDUSTRIAL PROCESSING, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 40. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY INDUSTRIAL PROCESSING, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 41. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY NATURAL RESOURCES & ENVIRONMENT, 2018-2030 (USD BILLION)
  • TABLE 42. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY NATURAL RESOURCES & ENVIRONMENT, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 43. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY NATURAL RESOURCES & ENVIRONMENT, BY REGION, 2018-2030 (USD BILLION)
  • TABLE 44. AMERICAS BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 45. AMERICAS BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
  • TABLE 46. AMERICAS BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 47. AMERICAS BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 48. ARGENTINA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 49. ARGENTINA BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 50. ARGENTINA BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 51. BRAZIL BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 52. BRAZIL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 53. BRAZIL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 54. CANADA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 55. CANADA BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 56. CANADA BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 57. MEXICO BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 58. MEXICO BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 59. MEXICO BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 60. UNITED STATES BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 61. UNITED STATES BIOTECHNOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD BILLION)
  • TABLE 62. UNITED STATES BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 63. UNITED STATES BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 64. ASIA-PACIFIC BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 65. ASIA-PACIFIC BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
  • TABLE 66. ASIA-PACIFIC BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 67. ASIA-PACIFIC BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 68. AUSTRALIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 69. AUSTRALIA BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 70. AUSTRALIA BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 71. CHINA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 72. CHINA BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 73. CHINA BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 74. INDIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 75. INDIA BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 76. INDIA BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 77. INDONESIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 78. INDONESIA BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 79. INDONESIA BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 80. JAPAN BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 81. JAPAN BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 82. JAPAN BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 83. MALAYSIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 84. MALAYSIA BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 85. MALAYSIA BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 86. PHILIPPINES BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 87. PHILIPPINES BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 88. PHILIPPINES BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 89. SINGAPORE BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 90. SINGAPORE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 91. SINGAPORE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 92. SOUTH KOREA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 93. SOUTH KOREA BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 94. SOUTH KOREA BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 95. TAIWAN BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 96. TAIWAN BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 97. TAIWAN BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 98. THAILAND BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 99. THAILAND BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 100. THAILAND BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 101. VIETNAM BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 102. VIETNAM BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 103. VIETNAM BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 108. DENMARK BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 109. DENMARK BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 110. DENMARK BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 111. EGYPT BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 112. EGYPT BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 113. EGYPT BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 114. FINLAND BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 115. FINLAND BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 116. FINLAND BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 117. FRANCE BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 118. FRANCE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 119. FRANCE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 120. GERMANY BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 121. GERMANY BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 122. GERMANY BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 123. ISRAEL BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 124. ISRAEL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 125. ISRAEL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 126. ITALY BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 127. ITALY BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 128. ITALY BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 129. NETHERLANDS BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 130. NETHERLANDS BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 131. NETHERLANDS BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 132. NIGERIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 133. NIGERIA BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 134. NIGERIA BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 135. NORWAY BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 136. NORWAY BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 137. NORWAY BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 138. POLAND BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 139. POLAND BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 140. POLAND BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 141. QATAR BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 142. QATAR BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 143. QATAR BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 144. RUSSIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 145. RUSSIA BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 146. RUSSIA BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 147. SAUDI ARABIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 148. SAUDI ARABIA BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 149. SAUDI ARABIA BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 150. SOUTH AFRICA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 151. SOUTH AFRICA BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 152. SOUTH AFRICA BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 153. SPAIN BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 154. SPAIN BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 155. SPAIN BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 156. SWEDEN BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 157. SWEDEN BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 158. SWEDEN BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 159. SWITZERLAND BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 160. SWITZERLAND BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 161. SWITZERLAND BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 162. TURKEY BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 163. TURKEY BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 164. TURKEY BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 165. UNITED ARAB EMIRATES BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 166. UNITED ARAB EMIRATES BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 167. UNITED ARAB EMIRATES BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 168. UNITED KINGDOM BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
  • TABLE 169. UNITED KINGDOM BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
  • TABLE 170. UNITED KINGDOM BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
  • TABLE 171. GLOBAL BIOTECHNOLOGY MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
  • TABLE 172. GLOBAL BIOTECHNOLOGY MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
  • TABLE 173. GLOBAL BIOTECHNOLOGY MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
  • TABLE 174. GLOBAL BIOTECHNOLOGY MARKET RANKING, BY KEY PLAYER, 2022
  • TABLE 175. GLOBAL BIOTECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 176. GLOBAL BIOTECHNOLOGY MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
  • TABLE 177. GLOBAL BIOTECHNOLOGY MARKET MERGER & ACQUISITION
  • TABLE 178. GLOBAL BIOTECHNOLOGY MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 179. GLOBAL BIOTECHNOLOGY MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 180. GLOBAL BIOTECHNOLOGY MARKET INVESTMENT & FUNDING
  • TABLE 181. GLOBAL BIOTECHNOLOGY MARKET AWARD, RECOGNITION, & EXPANSION
  • TABLE 182. GLOBAL BIOTECHNOLOGY MARKET: LICENSE & PRICING